These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 15205916)

  • 1. Myocardial infarction during factor IX infusion in hemophilia B: case report and review of the literature.
    Najaf SM; Malik A; Quraishi AU; Kazmi K; Kakepoto GN
    Ann Hematol; 2004 Sep; 83(9):604-7. PubMed ID: 15205916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current management of hemophilia B.
    Roberts HR; Eberst ME
    Hematol Oncol Clin North Am; 1993 Dec; 7(6):1269-80. PubMed ID: 8294316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac surgery in patients with haemophilia B: a case report and review of the literature.
    Krakow EF; Walker I; Lamy A; Anderson JA
    Haemophilia; 2009 Jan; 15(1):108-13. PubMed ID: 18976256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Non-activated and activated prothrombin complex concentrates, Proplex and Feiba, in the treatment of a hemophilia B patient with high titer inhibitor against factor IX].
    Niiya K; Hirose S; Taguchi H; Miyoshi I
    Rinsho Ketsueki; 1985 Jun; 26(6):980-4. PubMed ID: 3877825
    [No Abstract]   [Full Text] [Related]  

  • 5. Vascular lesions in hemophilia B.
    Steinberg MH; Breiling BJ
    N Engl J Med; 1973 Sep; 289(11):592. PubMed ID: 4723113
    [No Abstract]   [Full Text] [Related]  

  • 6. Orthotopic liver transplantation for hepatitis C infection: the best Christmas present?
    Johnston SD; McNulty O; Mayne E; Callender ME
    Ulster Med J; 1998 Nov; 67(2):134-6. PubMed ID: 9885554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonoperative management of delayed splenic rupture in a patient with hemophilia B.
    Terry NE; Boswell WC
    J Pediatr Surg; 2006 Sep; 41(9):1607-9. PubMed ID: 16952601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of recombinant factor IX and thromboelastography in a patient with hemophilia B undergoing liver transplantation: a case report.
    De Pietri L; Masetti M; Montalti R; Begliomini B; Reggiani A; Barbieri E; Biagioni E; Marietta M; Romano A; Pasetto A; Gerunda GE
    Transplant Proc; 2008; 40(6):2077-9. PubMed ID: 18675136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombogenicity associated with factor IX complex concentrates.
    Lusher JM
    Semin Hematol; 1991 Jul; 28(3 Suppl 6):3-5. PubMed ID: 1780767
    [No Abstract]   [Full Text] [Related]  

  • 10. Anaphylactic response to factor IX replacement therapy in haemophilia B patients: complete gene deletions confer the highest risk.
    Thorland EC; Drost JB; Lusher JM; Warrier I; Shapiro A; Koerper MA; Dimichele D; Westman J; Key NS; Sommer SS
    Haemophilia; 1999 Mar; 5(2):101-5. PubMed ID: 10215957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spinal epidural haematoma in a patient with haemophilia B.
    Balkan C; Kavakli K; Karapinar D
    Haemophilia; 2006 Jul; 12(4):437-40. PubMed ID: 16834748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute myelogenous leukemia in a patient with severe factor IX deficiency.
    Clark C; Gidvani VK
    Pediatr Blood Cancer; 2011 Jan; 56(1):156-7. PubMed ID: 20842752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coronary bypass in a patient with hemophilia B, or Christmas disease. Case report.
    Tourbaf KD; Bettigole RE; Zizzi JA; Subramanian S; Andersen MN
    J Thorac Cardiovasc Surg; 1979 Apr; 77(4):562-9. PubMed ID: 311396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Extracorporeal shockwave lithotripsy and hemophilia: apropos of a case].
    Brunet P; Rigot JM; Coupez B; Mazeman E
    Prog Urol; 1995 Feb; 5(1):99-101. PubMed ID: 7719366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factor IX thrombogenicity: in vivo effects on coagulation activation and a case report of disseminated intravascular coagulation.
    Small M; Lowe GD; Douglas JT; Forbes CD; Prentice CR
    Thromb Haemost; 1982 Aug; 48(1):76-7. PubMed ID: 7135346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-thrombotic-, non-inhibitor-associated adverse reactions to coagulation factor concentrates for treatment of patients with hemophilia and von Willebrand's disease: a systematic review of prospective studies.
    Franchini M; Makris M; Santagostino E; Coppola A; Mannucci PM
    Haemophilia; 2012 May; 18(3):e164-72. PubMed ID: 22250981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Markers of hypercoagulability in patients with hemophilia B given repeated, large doses of factor IX concentrates during and after surgery.
    Santagostino E; Mannucci PM; Gringeri A; Tagariello G; Baudo F; Bauer KA; Rosenberg RD
    Thromb Haemost; 1994 Jun; 71(6):737-40. PubMed ID: 7974341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factor IX deficiency in Gaucher disease. An in vitro phenomenon.
    Boklan BF; Sawitsky A
    Arch Intern Med; 1976 Apr; 136(4):489-92. PubMed ID: 1267559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and efficacy of monoclonal antibody purified factor IX concentrate in previously untreated patients with hemophilia B.
    Shapiro AD; Ragni MV; Lusher JM; Culbert S; Koerper MA; Bergman GE; Hannan MM
    Thromb Haemost; 1996 Jan; 75(1):30-5. PubMed ID: 8713776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Use of 2 preparations of factor IX concentrate in the treatment of a patient with hemophilia B].
    den Ottolander GJ
    Ned Tijdschr Geneeskd; 1972 Jul; 116(30):1278-82. PubMed ID: 5041298
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.